- OP Labs formerly Oxford Peptides.
- Batch HPLC tested at ≥ 99% purity.
- Storage: –20 °C long term; 2–8 °C short term.
- Sold for research purposes only.
CJC-1295 (Without DAC)
Synonyms: CJC-1295, Modified GHRH (1–29) analogue, Tetrasubstituted GHRH (1–29), Growth Hormone–Releasing Hormone analogue.
Molecular Formula: C152H252N44O42
Molecular Weight: 3367.9 g/mol (approximate)
CAS Number: 863288-34-0
Peptide Classification: Synthetic growth hormone–releasing hormone (GHRH 1–29) analogue.
Solubility: Soluble in sterile water, acetic acid, and physiological buffers (e.g., PBS)
Description & Mechanism
CJC-1295 without DAC is a synthetic analogue of growth hormone–releasing hormone (GHRH 1–29) incorporating amino acid substitutions designed to enhance stability relative to the native peptide. Unlike DAC-conjugated variants, CJC-1295 does not contain a drug affinity complex and therefore exhibits pharmacokinetic behaviour characteristic of non-conjugated GHRH analogues in experimental systems.
In biochemical and cellular research models, CJC-1295 interacts with the GHRH receptor expressed on pituitary-derived cells, initiating intracellular signalling cascades associated with endocrine regulation. Preclinical research has examined receptor binding properties, activation kinetics, and downstream signalling under short-duration exposure conditions. Observed molecular and physiological responses are dependent on experimental design, concentration, and model system, and are used to investigate GHRH receptor signalling rather than defined biological or physiological outcomes.
Applications in Research
- As a molecular probe to study GHRH receptor binding and activation dynamics.
- Investigation of growth hormone axis signalling and endocrine feedback mechanisms.
- In cellular assays examining downstream transcriptional and signalling responses.
Specifications Summary
| Parameter | Typical Value / Range |
|---|---|
| Purity (HPLC) | ≥ 99% |
| Appearance | White to off-white lyophilised powder |
| Molecular Weight | ~3,367.9 g/mol |
| Peptide Type | Synthetic GHRH analogue (without DAC) |
| Solubility | Water, buffered aqueous solutions |
| Storage | –20 °C, desiccated, dark |
| Pack Size | 2 mg |
References
- Wu, Z., et al. (2009). “Synthesis and characterization of growth hormone releasing hormone analogues.” Peptides, 30(5), 783–789. https://doi.org/10.1016/j.peptides.2009.01.010
- Frohman, L. A., Downs, T. R., Heimer, E. P., et al. (1989). “Studies of the biological activity of analogs of growth hormone-releasing factor (GRF).” Endocrinology, 124(1), 279–284. https://doi.org/10.1210/endo-124-1-279
- Camanni, F., Ghigo, E., Arvat, E. (1998). “Growth hormone-releasing peptides and their analogs.” Frontiers in Neuroendocrinology, 19(1), 47–72. https://doi.org/10.1006/frne.1997.0166
Keywords: CJC-1295 without DAC, CJC without DAC, CJC no DAC, CJC1295 no DAC, CJC1295 without DAC.








